Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.


Fundamentals of Stability Testing Workshop

11AM - 5PM 
2nd of September 2026


Objectives:

  • Understand key stability guidelines, including International and Saudi Food and Drug Authority requirements. 
  • Explain the purpose, types, and key parameters of stability studies.
  • Apply specifications, analytical methods, and acceptance criteria. 
  • Interpret stability data and determine product shelf life. 
  • Describe in-use, compatibility, and forced degradation studies. 
  • Recognize SFDA-specific regulatory expectations.
Register To Attend


Workshop Agenda

2nd of September

11:00 – 11:45
Major global & local guidelines (ICH Q1A(R2) & SFDA).

11:45 – 12:15
Purpose & key parameters.

12:15 – 12:45
Types: Long-term, accelerated, and intermediate conditions.

12:45 – 13:00
Discussion

13:00 – 13:15
Coffee Break

13:15 – 13:45
Specification, analytical methods and acceptance criteria.

13:45 – 14:15
Reporting: Data presentation, statistical analyses, and shelf-life determination.

14:15 – 14:45
In-Use Stability Studies: Purpose and scope.

14:45 – 15:00
Discussion

15:00 – 15:45
Lunch break

15:45 – 16:05
Compatibility Studies for Injectables: Purpose and scope.

16:05 – 16:25
Forced Degradation Studies: Purpose, scope and regulatory impact.

16:25 – 16:45
SFDA specific considerations.

16:45 – 17:00
Q & A


Meet Our Instructor

Abdullah Bader Alreshaidan is a distinguished regulatory affairs executive with 15 years of experience in the pharmaceutical industry. He spent nine years at the Saudi Food and Drug Authority (SFDA) before taking on leadership roles in the private sector, including positions at Servier, Saudi Amarox, and SPIMACO ADDWAEIH. He currently serves as Regulatory Affairs Director at Spectropharma. Abdullah holds a B.Sc. in Pharmaceutical Sciences from King Saud University and an M.Sc. in Drug Discovery and Pharmaceutical Sciences from the University of Nottingham, and is recognized for his strategic leadership and expertise in regulatory affairs.


Powered By